Genetics of congenital heart diseases in syndromic and non-syndromic patients: New advances and clinical implications

Journal of Cardiovascular Medicine

Volumn 8, Issue 1, 2007, Pages 7-11

  Piacentini, Gerardo ^a   Digilio, M Cristina ^b   Sarkozy, Anna ^a   Placidi, Silvia ^a   Dallapiccola, Bruno ^a   Marino, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Congenital heart disease; Genes; Genetic syndromes; Genetics

Indexed keywords

TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5;

CHROMOSOME 22Q; CHROMOSOME 22Q11 DELETION SYNDROME; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CONGENITAL HEART DISEASE; CORRELATION ANALYSIS; CYTOGENETICS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DOWN SYNDROME; ELLIS VAN CREVELD SYNDROME; GENE ISOLATION; GENE MUTATION; GENETIC LINKAGE; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HETEROTAXIA; HOLT ORAM SYNDROME; HUMAN; LEOPARD SYNDROME; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NOONAN SYNDROME; PROGNOSIS; REVIEW; TRANSGENE; TURNER SYNDROME; WILLIAMS BEUREN SYNDROME;

ABNORMALITIES, MULTIPLE; ANIMALS; DOWN SYNDROME; ELLIS-VAN CREVELD SYNDROME; GENOME, HUMAN; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; NOONAN SYNDROME; PATIENT SELECTION; PHENOTYPE; PROGNOSIS; TURNER SYNDROME; WILLIAMS SYNDROME;

EID: 33846611949     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000247428.51828.51     Document Type: Review

References (81)

1. Ferencz C, Rubin JD, Loffredo CA, Magee CA. Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981-1989. Mount Kisco, NY: Futura Publishing Company; 1993.
2. Ferencz C, Loffredo CA, Correa-Villasenor A, Magee CA. Genetic and environmental risk factors of major cardiovascular malformation. The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing Company; 1997.
3. Clark EB. Mechanisms in the pathogenesis of congenital heart defects. In: Pierpont ME, Moller J, editors. The genetics of cardiovascular disease. Boston, MA: Martinus-Nijoff; 1986. pp. 3-11.
4. Clark EB. Pathogenetic mechanism of congenital cardiovascular malformations revisited. Seminar Perinatal 1996; 29:465-472.
5. Marino B, Digilio MC. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 2000; 9:303-315.
6. Shapiro BL. Down syndrome - a disruption of homeostasis. Am J Med Genet 1983; 14:241-269.
7. Digilio MC, Casey B, Toscano A, Calabro R, Pacileo G, Marasini M, et al. Complete transposition of the great arteries. Patterns of congenital heart disease in familial precurrence. Circulation 2001; 104:2809-2814.
8. Piacentini G, Digilio MC, Capolino R, De Zorzi A, Toscano A, Sarkozy A, et al. Familial recurrence of heart defects in subjects with congenitally corrected transposition of the great arteries. Am J Med Genet A 2005; 137:176-180.
9. Marino B, Vairo U, Corno A, Nava S, Guccione P, Calabro R, Marcelletti C. Atrioventricular canal in Down syndrome. Prevalence of associated cardiac malformations compared with patients without Down syndrome. Am J Dis Child 1990; 144:1120-1122.
10. Carmi R, Boughman JA, Ferencz C. Endocardial cushion defect: further studies of 'isolated' versus 'syndromic' occurrence. Am J Med Genet 1992; 43:569-575.
11. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. Atrioventricular canal defect without Down syndrome: a heterogeneous malformation. Am J Med Genet 1999; 85:140-146.
12. De Biase L, Di Ciommo V, Ballerini L, Bevilacqua M, Martelletti C, Marino B. Prevalence of left-sided obstructive lesions in patients with atrioventricular canal without Down syndrome. J Thorac Cardiovasc Surg 1986; 91: 467-469.
13. Marino B. Left-sided cardiac obstruction in patients with Down syndrome. J Pediatr 1989; 115:834-835.
14. Marino B. Patterns of congenital heart disease and associated cardiac anomalies in children with Down syndrome. In: Marino B, Pueschel SM, editors. Heart disease in persons with Down syndrome. Baltimore: Paul Brookes; 1996.
15. Hall JG, Gilchrist DM. Turner syndrome and its variants. Pediatr Clin North Am 1990; 37:1421-1436.
16. Miller MJ, Geffner ME, Lippe BM, Itami RM, Kaplan SA, DiSessa TG, et al. Echocardiography reveals a high incidence of bicuspid aortic valve in Turner syndrome. J Pediatr 1983; 102:47-50.
17. Surerus E, Huggon IC, Allan LD. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 2003; 22:264-267.
18. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994; 71:433-436.
19. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 1998; 133:688-692.
20. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998; 101:E11.
21. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112:101-117.
22. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34:798-804.
23. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, et al. The Philadelphia story. The 22q11.2 deletion: report on 250 patients. Genet Couns 1999; 10:11-24.
24. Momma K, Kondo C, Matsuoka R, Takao A. Cardiac anomalies associated with a chromosome 22q11 deletion in patients with conotruncal anomaly face syndrome. Am J Cardiol 1996; 78:591-594.
25. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32:492-498.
26. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B. Congenital heart defects in patients with DiGeorge/Velocardiofacial syndrome and del22q11. Genet Couns 1999; 10:25-33.
27. Marino B, Digilio MC, Toscano A, Anaclerio S, Giannotti A, Feltri C, et al. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med 2001; 3:45-48.
28. Momma K, Kondo C, Ando M, Matsuoka R, Takao A. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol 1995; 76:618-621.
29. Marino B, Digilio MC, Grazioli S, Formigari R, Mingarelli R, Giannotti A, Dallapiccola B. Associated cardiac anomalies in isolated and syndromic patients with tetralogy of Fallot. Am J Cardiol 1996; 77:505-508.
30. Maeda J, Yamagishi H, Matsuoka R, Ishihara J, Tokumura M, Fukushima H, et al. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 2000; 92:269-272.
31. Johnson MC, Strauss AW, Dowton SB, Spray TL, Huddleston CB, Wood MK, et al. Deletion within chromosome 22 is common in patients with absent pulmonary valve syndrome. Am J Cardiol 1995; 76:66-69.
32. Momma K, Kondo C,Matsuoka R. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion. J Am Coll Cardiol 1996; 27:198-202.
33. Chessa M, Butera G, Bonhoeffer P, Iserin L, Kachaner J, Lyonnet S, et al. Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia-ventricular septal defect. Heart 1998; 79:186-190.
34. Hofbeck M, Rauch A, Buheitel G, Leipold G, von der Emde J, Pfeiffer R, Singer H. Monosomy 22q11 in patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries. Heart 1998; 79:180-185.
35. Anaclerio S, Marino B, Carotti A, Digilio MC, Toscano A, Gitto P, et al. Pulmonary atresia with ventricular septal defect: prevalence of deletion 22q11 in the different anatomic patterns. Ital Heart J 2001; 2:384-387.
36. Momma K, Ando M, Matsuoka R. Truncus arteriosus communis associated with chromosome 22q11 deletion. J Am Coll Cardiol 1997; 30:1067-1071.
37. Marino B, Digilio MC, Toscano A. Common arterial trunk, DiGeorge syndrome and microdeletion 22q11. Prog Pediatr Cardiol 2002; 15:9-17.
38. Marino B, Digilio MC, Persiani M, Di Donato R, Toscano A, Giannotti A, Dallapiccola B. Deletion 22q11 in patients with interrupted aortic arch. Am J Cardiol 1999; 84:360-361.
39. Momma K, Ando M, Matsuoka R, Joo K. Interruption of the aortic arch associated with deletion of chromosome 22q11 is associated with a subarterial and doubly committed ventricular septal defect in Japanese patients. Cardiol Young 1999; 9:451-457.
40. Greenberg F. Williams syndrome professional symposium. Am J Med Genet 1990; 6:85-88.
41. Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL. Natural history of Williams syndrome: physical characteristics. J Pediatr 1988; 113:318-326.
42. Ewart AK, Morris CA, Atkinson D, Jin W, Sternes K, Spallone P, et al. Hemizygosity at elastin locus in a developmental disorder Williams syndrome. Nat Genet 1993; 5:11-16.
43. Hallidie-Smith KA, Karas S. Cardiac anomalies in Williams-Beuren syndrome. Arch Dis Child 1988; 63:809-813.
44. Brand A, Karen A, Reifen RM, Gross-Kieselstein E. Echocardiographic and Doppler findings in the Williams syndrome. Am J Cardiol 1989; 63:633-635.
45. Giddings NG, Finley JP, Nanton MA, Douglas LR. The natural course of supravalvular aortic stenosis and peripheral pulmonary artery stenosis in William's syndrome. Br Heart J 1989; 62:315-319.
46. Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, Keating MT. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 1993; 73:159-168.
47. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG, Seidman CE. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Devel Biol 1999; 211:100-108.
48. Bonnet D, Pelet A, Legeai-Mallet L, Sidi D, Mathieu M, Parent P, et al. A gene for Holt-Oram syndrome maps to the distal long arm of chromosome 12. Nat Genet 1994; 6:405-408.
49. Terrett JA, Newbury-Ecob R, Cross GS, Fenton I, Raeburn JA, Young ID, Brook JD. Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q. Nat Genet 1994; 6:401-404.
50. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997; 15:30-35.
51. Heinritz W, Moschik A, Kujat A, Spranger S, Heilbronner H, Demuth S, et al. Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome. Heart 2005; 91:383-384.
52. Kumar A, Van Mierop LHS, Epstein ML. Pathogenetic implications of muscular ventricular septal defect in Holt-Oram syndrome. Am J Cardiol 1994; 73:993-995.
53. Sletten LJ, Pierpont MEM. Variation in severity of cardiac disease in Holt-Oram syndrome. Am J Med Genet 1996; 65:128-132.
54. Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet 2000; 24:283-286.
55. Digilio MC, Marino B, Giannotti A, Dallapiccola B. Atrioventricular canal defect and postaxial polydactyly indicating phenotypic overlap of Ellis-van Creveld and Kaufman-McKusick syndromes. Pediatr Cardiol 1997; 18:74-75.
56. Allanson JE. Noonan syndrome. J Med Genet 1987; 24:9-13.
57. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29:465-468.
58. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, et al. Grouping of multiple-lentigines/LEONARD and Noonan Syndromes on the PTPN11 gene. Am J Hum Genet 2002; 71:389-394.
59. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, et al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 2003; 40:704-708.
60. Kosaki R, Gebbia M, Kosaki K, Lewin M, Bowers P, Towbin JA, Casey B. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet 1999; 82: 70-76.
61. Peoples WM, Moller JH, Edwards JE. Polysplenia: a review of 146 cases. Pediatr Cardiol 1983; 4:129-138.
62. Lin AE, Ticho BS, Houde K, Westgate M, Holmes LB. Heterotaxy: associated conditions and hospital-based prevalence in newborns. Genet Med 2000; 2:157-172.
63. Phoon CK, Neill CA. Asplenia syndrome: insight into embryology through an analysis of cardiac and extracardiac anomalies. Am J Cardiol 1994; 73:581-587.
64. Rose V, Izukawa T, Moes CAF. Syndrome of asplenia and polysplenia. A review of cardiac and non-cardiac malformations in 60 cases with special reference to diagnosis and prognosis. Br Heart J 1975; 37: 840-852.
65. Gebbia M, Ferrero GB, Pilia G, Bassi MT, Aylsworth A, Penman-Splitt M, et al. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 1997; 13:305-308.
66. Bamford RN, Roessler E, Burdine RD, Saplakoglu U, dela Cruz J, Splitt M, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000; 26:365-369.
67. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999; 401:279-282.
68. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998; 393:786-790.
69. Tsukui T, Capdevila J, Tamura K, Ruiz-Lozano P, Rodriguez-Esteban C, Yonei-Tamura S, et al. Multiple left-right asymmetry defects in Shh -/-mutant mice unveil a convergence of the Shh and retinoic acid pathway in the control of Lefty-1. Proc Natl Acad Sci U S A 1999; 96:11376-11381.
70. Meno C, Shimono A, Saijoh Y, Yashiro K, Mochida K, Ohishi S, et al. lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal. Cell 1998; 94:287-297.
71. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, Esposito G, et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 2005; 42:e16.
72. Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005; 37:423-428.
73. Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, Maslen CL. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 2003; 72:1047-1052.
74. Pizzuti A, Sarkozy A, Newton AL, Conti E, Flex E, Digilio MC, et al. Mutations in ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 2003; 22:372-377.
75. Muncke N, Jung C, Rudiger H, Ulmer H, Roeth R, Hubert A, et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 2003; 108:2843-2850.
76. Reamon-Buettner SM, Borlak J. TBX5 mutations in non-Holt-Oram (HOS) malformed hearts. Hum Mutat 2004; 24:104-110.
77. Mégarbané A, Salem N, Stephan E, Ashoush R, Lenoir D, Delague V, et al. X-linked transposition of the great arteries and incomplete penetrance among males with nonsense mutation in ZIC3. Eur J Hum Genet 2000; 8:704-708.
78. Komajda M, Charron P. How will the human genome project change cardiovascular medicine? Heart 2001; 86:123-124.
79. Formigari R, Di Donato RM, Gargiulo G, Di Carlo D, Feltri C, Picchio FM, Marino B. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome. Ann Thorac Surg 2004; 78:666-672.
80. Anaclerio S, Di Ciommo V, Michielon G, Digilio MC, Formigari R, Picchio FM, et al. Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J 2004; 5:1-5.
81. Michielon G, Marino B, Formigari R, Gargiulo G, Picchio F, Digilio MC, et al. Genetic syndromes and outcome after surgical correction of tetralogy of Fallot. Ann Thorac Surg 2006; 81:968-975.